Statement on the FDA Pharmacy Compounding Advisory Committee Vote on Peptides

Empower issued the following after the FDA Pharmacy Compounding Advisory Committee voted to recommend that six out of seven peptides under review receive Category 1 inclusion, which will make them eligible for pharmacy compounding when confirmed by the FDA: “Today is a win for patient access. The PCAC’s recommendation that six out of seven peptides … Statement on the FDA Pharmacy Compounding Advisory Committee Vote on Peptides






